Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction

Endocrine-Related Cancer

Volumn 15, Issue 2, 2008, Pages 451-463

  Matsumoto, Mitsuyo ^a   Yamaguchi, Yuri ^b   Seino, Yuko ^b   Hatakeyama, Atsushi ^a   Takei, Hiroyuki ^b   Niikura, Hitoshi ^a   Ito, Kiyoshi ^a   Suzuki, Takashi ^a   Sasano, Hironobu ^a   Yaegashi, Nobuo ^a   Hayashi, Shin Ichi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; EXEMESTANE; FULVESTRANT; GREEN FLUORESCENT PROTEIN; LETROZOLE; TESTOSTERONE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN SYNTHESIS; FEMALE; GENE ACTIVATION; GENE ACTIVITY; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; STROMA CELL; TISSUE SECTION;

17-HYDROXYSTEROID DEHYDROGENASES; ADENOVIRIDAE; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STROMAL CELLS; TESTOSTERONE;

EID: 45849104657     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0227     Document Type: Article

References (40)

1. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC & Simpson ER 1981 Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. Journal of Clinical Endocrinology and Metabolism 53 412-417.
2. Berstein L, Maximov S, Gershfeld E, Meshkova I, Gamajunova V, Tsyrlina E, Larionov A, Kovalevskij A & Vasilyev D 2002 Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects. European Journal of Obstetrics, Gynecology, and Reproductive Biology 105 161-165.
3. Berstein LM, Tchernobrovkina AE, Gamajunova VB, Kovalevskij AJ, Vasilyev DA, Chepik OF, Turkevitch EA, Tsyrlina EV, Maximov SJ, Ashrafian LA et al. 2003 Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. Journal of Cancer Research and Clinical Oncology 129 245-249.
4. Brueggemeier RW, Hackett JC & Diaz-Cruz ES 2005 Aromatase inhibitor in the treatment of breast cancer. Endocrine Reviews 26 331-345.
5. Bulun SE, Economos K, Miller D & Simpson ER 1994 CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. Journal of Clinical Endocrinology and Metabolism 79 1831-1834.
6. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B et al. 2005 Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacological Reviews 57 359-383.
7. Bunone G, Briand P-A, Miksicek RJ & Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO Journal 15 2174-2183.
8. Burnett AF, Bahador A & Amezcua C 2004 Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy. Gynecologic Oncology 94 832-834.
9. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S & Nakshatri H 2001 Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. Journal of Biological Chemistry 276 9817-9824.
10. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
11. Dickson RB & Lippman ME 1995 Growth factor in breast cancer. Endocrine Reviews 16 559-589.
12. Duffy S & Greenwood M 2003 The endometrial cancer data from the ATAC (arimidex, tamoxifen, alone or in combination) trial indicates a protective effect on anastrozole (armidex) upon the endometrium. Breast Cancer Research and Treatment 82 (Supplement 1) S29.
13. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DI & Cronin WM 1994 Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Journal of the National Cancer Institute 86 527-537.
14. Font de Mora J & Brown M 2000 AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Molecular and Cellular Biology 20 5041-5047.
15. Grilli S 2006 Tamoxifen (TAM): the dispute goes on. Annali Dell'Istituto Superiore di Sanità 42 170-173.
16. Grimm SW & Dyroff MC 1997 Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase. Drug Metabolism and Disposition: The Biological Fate of Chemicals 25 598-602.
17. Hecht JL & Mutter GL 2006 Molecular and pathologic aspects of endometrial carcinogenesis. Journal of Clinical Oncology 24 4783-4791.
18. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA & Korach KS 1996 Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137 1735-1744.
19. Ito K 2007 Hormone replacement therapy and cancer: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast. Tohoku Journal of Experimental Medicine 212 1-12.
20. Ito K, Utsunomiya H, Suzuki T, Saitou S, Akahira J, Okamura K, Yaegashi N & Sasano H 2006 17β-Hydroxysteroid dehydrogenases in human endometrium and its disorders. Molecular and Cellular Endocrinology 248 136-140.
21. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H et al. 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1492-1494.
22. Landis SH, Murray T, Bolden S & Wingo PA 1999 Cancer statics, 1999. CA: A Cancer Journal for Clinicians 49 8-31.
23. Leunen M, Breugelmans M, De Sutter Ph, Bourgain C & Amy JJ 2004 Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecologic Oncology 95 769-771.
24. Lian Z, De Luca P & Di Cristofano A 2006 Gene expression analysis reveals a signature of estrogen receptor activation upon of Pten in mouse model of endometrial cancer. Journal of Cellular Physiology 208 255-266.
25. Mochizuki T, Sakai K & Iwashita M 2006 Effect of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro. Growth Hormone and IGF Research 16 202-210.
26. Nagamani M, Hannigan EV, Dillard EA Jr & Van Dinh T 1986 Ovarian steroid secretion in postmenopausal women with and without endometrial cancer. Journal of Clinical Endocrinology and Metabolism 62 508-512.
27. Naitoh K, Honjo H, Yamamoto T, Urabe M, Ogino Y, Yasumura T & Nambara T 1989 Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. Journal of Steroid Biochemistry 33 1049-1054.
28. Omoto Y, Kobayashi Y, Nishida K, Tsuchiya E, Eguchi H, Nakagawa K, Ishikawa Y, Yamori T, Iwase H, Fujii Y et al. 2001 Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochemical and Biophysical Research Communications 285 340-347.
29. O'Toole SA, Dunn E, Shppard BL, Shells O, O'Leary JJ, Wuttke W & Seidlova-Wuttke D 2005 Oestrogen regulated gene expression in normal and malignant endometrial tissue. Maturitas 51 187-198.
30. Pasqualini JR & Chetrite GS 2006 Estradiol as an anti-aromatase agent in human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 98 12-17.
31. Rose PG, Brunette VL, Vanle L, Bell J, Walker JL & Lee RB 2000 A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a gynecologic oncology group study. Gynecologic Oncology 78 212-216.
32. Rowan BG, Weigel NL & O'Malley BW 2000 Phosphorylation of steroid receptor coactivator-1: identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. Journal of Biological Chemistry 275 4475-4483.
33. Rutanen EM, Pekonen F & Wahlstrom T 1993 Insulin-like growth factors and their binding proteins in benign and malignant uterine diseases. Growth Regulation 3 74-77.
34. Sasano H, Kaga K, Sato S, Yajima A, Naura H & Harada N 1996 Aromatase cytochrome P450 gene expression in endometrial carcinoma. British Journal of Cancer 74 1541-1544.
35. Segawa T, Shozu M, Murakami K, Kasai T, Shinohara K, Nomura K, Ohno S & Inoue M 2005 Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival. Clinical Cancer Research 11 2188-2194.
36. Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB et al. 2003 Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI3-K/Akt pathway. Oncogene 22 7998-8011.
37. Takase Y, Levesque MH, Luu-The V, El-Alfy M, Labrie F & Pelletier G 2006 Expression of enzymes involved in estrogen metabolism in human prostate. Journal of Histochemistry and Cytochemistry 54 911-921.
38. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3 RESEARCH0034.
39. Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S & Yajima A 1995 Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. American Journal of Pathology 146 491-500.
40. Yamaguchi Y, Takei H, Suemasu K, Kobayashi Y, Kurosumi M, Harada N & Hayashi S 2005 Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer. Cancer Research 65 1653-1662.